Concepedia

Tegan L. Cheng

TL

31

Publications

861

Citations

17

H-Index

2011

Active since

Affiliations

Children's Hospital at Westmead(Current)

The University of Sydney

Garvan Institute of Medical Research

Novartis (Switzerland)

Anzac Research Institute

Tegan L. Cheng is an author at Children's Hospital at Westmead specializing in medicine, orthopaedics, and osteoporosis.

ORCID

Top concepts

Publications per year

2011–2023

31

Publications

31

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

Michelle M. McDonald, Michaela R. Reagan, Scott E. Youlten et al. · Blood · 2017 · 182 citations · Full text

Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer

Chun‐Yi Lu, H-L Tsai, Y-H Uen et al. · British Journal of Cancer · 2013 · 76 citations · Full text

Fabrication of a Biodegradable Implant with Tunable Characteristics for Bone Implant Applications

Iman Manavitehrani, Ali Fathi, Yiwei Wang et al. · Biomacromolecules · 2017 · 52 citations

A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells

Jad El‐Hoss, Tegan L. Cheng, Nicole Yu et al. · Journal of Bone and Mineral Research · 2011 · 51 citations

, , +20

Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta

David G. Little, Lauren Peacock, Kathy Mikulec et al. · Bone · 2017 · 34 citations

, , +13

Rows per page

1–5 of 31